Hirashima Mitsuomi, Kashio Yumiko, Nishi Nozomu, Yamauchi Akira, Imaizumi Tada-atsu, Kageshita Toshiro, Saita Naoki, Nakamura Takanori
Department of Immunology & Immunopathology, Kagawa Medical University, Kagawa, Japan.
Glycoconj J. 2002;19(7-9):593-600. doi: 10.1023/B:GLYC.0000014090.63206.2f.
We first cloned galectin-9 (Gal-9)/ecalectin as a T cell-derived eosinophil chemoattractant. Gal-9 plays a role in not only accumulation but also activation of eosinophils in experimental allergic models and human allergic patients, because Gal-9 induces eosinophil chemoattraction in vitro and in vivo and activates eosinophils in many aspects. Gal-9 requires divalent galactoside-binding activity but not the linker peptide of Gal-9 to exhibit its biological functions, and an unidentified matrix metalloproteinase is involved in the release of Gal-9. Our recent studies also showed that Gal-9 has other functions, such as cell differentiation, aggregation, adhesion, and death. Now, we and other groups are on the way of investigating the regulation and function of Gal-9 in a variety of physiological and pathological conditions. In this article, we will show the possible role of Gal-9 in physiological and pathological conditions by using our recent findings.
我们首先克隆了半乳糖凝集素-9(Gal-9)/上皮细胞半乳糖凝集素,将其作为一种T细胞衍生的嗜酸性粒细胞趋化因子。Gal-9不仅在实验性过敏模型和人类过敏患者中对嗜酸性粒细胞的聚集起作用,而且对其激活也起作用,因为Gal-9在体外和体内均可诱导嗜酸性粒细胞趋化,并在多个方面激活嗜酸性粒细胞。Gal-9发挥其生物学功能需要二价半乳糖苷结合活性,但不需要Gal-9的连接肽,并且一种未鉴定的基质金属蛋白酶参与Gal-9的释放。我们最近的研究还表明,Gal-9具有其他功能,如细胞分化、聚集、黏附和死亡。现在,我们和其他研究小组正在研究Gal-9在各种生理和病理条件下的调节作用和功能。在本文中,我们将利用我们最近的研究结果展示Gal-9在生理和病理条件下可能发挥的作用。